TAKAHASHI HIROO
No ORCID on file
· 98 papers in corpus
· active 1993-2004
Frequent coauthors
- FUJII Tomohito 70
- KOIZUMI Naoyuki 70
- TAKEGAWA SHIGEHIRO 56
- IWASHITA SHIGEKI 56
- NAKAGAWA Takayoshi 42
- OKADA Makoto 42
- MATSUI Teruaki 28
- SHIBATA Kenyu 28
- SATO KODO 28
- KAWACHI Tomoko 28
2002
Phenyl sulfamate derivatives represented by the following formula or salts thereof have a powerful inhibitory effect on steroid sulfatase and are hence useful for the prophylaxis or treatment of diseases associated with steroids such as est…
2002
Phenyl sulfamate derivatives represented by the following formula or salts thereof have a powerful inhibitory effect on steroid sulfatase and are hence useful for the prophylaxis or treatment of diseases associated with steroids such as est…
2002
Phenyl sulfamate derivatives represented by the following formula or salts thereof have a powerful inhibitory effect on steroid sulfatase and are hence useful for the prophylaxis or treatment of diseases associated with steroids such as est…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
Phenyl sulfamate derivatives of general formula (I) or salts thereof, exhibiting an excellent steroid sulfatase inhibitory activity and being therefore effective in the prevention or treatment of diseases related to steroids including estro…
2001
Phenyl sulfamate derivatives of general formula (I) or salts thereof, exhibiting an excellent steroid sulfatase inhibitory activity and being therefore effective in the prevention or treatment of diseases related to steroids including estro…
2001
Phenyl sulfamate derivatives of general formula (I) or salts thereof, exhibiting an excellent steroid sulfatase inhibitory activity and being therefore effective in the prevention or treatment of diseases related to steroids including estro…
2001
Phenyl sulfamate derivatives of general formula (I) or salts thereof, exhibiting an excellent steroid sulfatase inhibitory activity and being therefore effective in the prevention or treatment of diseases related to steroids including estro…
2001
Phenyl sulfamate derivatives of general formula (I) or salts thereof, exhibiting an excellent steroid sulfatase inhibitory activity and being therefore effective in the prevention or treatment of diseases related to steroids including estro…
2001
Phenyl sulfamate derivatives of general formula (I) or salts thereof, exhibiting an excellent steroid sulfatase inhibitory activity and being therefore effective in the prevention or treatment of diseases related to steroids including estro…
2001
Phenyl sulfamate derivatives of general formula (I) or salts thereof, exhibiting an excellent steroid sulfatase inhibitory activity and being therefore effective in the prevention or treatment of diseases related to steroids including estro…
2001
Phenyl sulfamate derivatives of general formula (I) or salts thereof, exhibiting an excellent steroid sulfatase inhibitory activity and being therefore effective in the prevention or treatment of diseases related to steroids including estro…